Alternatives to Qritive

Over the past twenty years, collaboration with innovative thinkers has enabled the identification, understanding, and reduction of errors from biopsy to data, resulting in significant advancements in tissue data mining tools, precision, workflow, and automation. Explore the realm of image analysis and tissue mining in both multi and highplexed images, where you can extract clinically significant patterns that provide insights into diseases, transforming your research tissue images into valuable knowledge. Discover the capabilities of CE-IVD APPs and workflows in image analysis, and redefine the approach to standardization through AI-powered pathology solutions that enhance diagnostic decision-making. The app center serves as your entry point to an extensive library filled with AI-driven applications, including those designed to adapt to your specific requirements. Additionally, you can peruse our collection of publications, guides, webinars, and posters to deepen your understanding of digital pathology and see how our software continually supports our clients in their research efforts. Embrace the future of pathology by leveraging these innovative tools and resources to elevate your work and contribute to advancing medical science.

CrelioHealth (formerly LiveHealth) enables customers to deliver a more digital & connected experience. CrelioHealth is used by more than 1500 medical labs and diagnostics centers to provide greater value to patients, doctors, and health organizations. Clear communication and our digital platform have proven to increase patient retention. You can provide seamless patient experience, from booking home collections to receiving reports or making payments via the app, SMS, and WhatsApp. Our integrated online payment system allows patients to make payments and view reports from their smartphone. Your patients can submit feedback directly on the app. Our customers have received over 200k patient feedbacks so far. With our mobile apps and easy interface, you can stay connected to your business at all hours. Instant delivery of reports to patients, doctors, and other organizations will reduce your TAT dramatically.

Paige's offerings have the potential to revolutionize the practice of pathologists by instilling greater certainty in diagnoses. The company is committed to pioneering a new era of clinical tools and predictive assessments that empower pathologists while redefining the field of oncology. With its innovative AI solutions, Paige paves the way for the future of pathology. The Paige Platform serves as a comprehensive, secure solution that ensures interoperability with laboratory information systems (LIS), integrates multiple scanners, offers cloud storage, facilitates case management, enables image review through FullFocus®, and incorporates advanced AI applications. The Paige Prostate suite of AI tools is specifically designed to aid pathologists in identifying suspicious areas, grading and quantifying tissue samples, and assessing perineural invasion (PNI) in prostate needle core biopsies. Similarly, the Paige Breast suite of AI applications supports pathologists in evaluating breast cancer by enabling the identification of malignancies in breast biopsies and the detection of metastases in lymph nodes associated with breast tissue. Collectively, these advancements not only enhance diagnostic accuracy but also improve patient outcomes in oncology.

Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.

Techcyte develops innovative machine learning applications specifically for cellular and liquid-based environments, designed to enhance the capabilities of laboratories and professionals in the field of digital diagnostics. Our commitment is to provide comprehensive solutions that offer a seamless and effective user experience at every stage, from sample preparation through to workflow execution and image interpretation, ensuring that we consistently deliver reliable outcomes. We recognize that the most significant breakthroughs in technology and healthcare stem from the ingenuity and dedication of talented individuals. Notably, our Cervical Cytology System serves as a groundbreaking screening instrument, enabling cytotechnologists and pathologists to analyze Hologic ThinPrep® or BD SurePath™ slides with greater efficiency by dramatically minimizing the number of cells they need to assess, all while highlighting the most diagnostically critical cells and organisms through our advanced AI-driven algorithm, optimized laboratory workflows, and integration with Laboratory Information Systems (LIS). This innovative approach not only streamlines the diagnostic process but also elevates the overall quality of patient care.

Ibex Medical Analytics stands at the forefront of AI-driven cancer diagnostics within the field of pathology. Our diverse team comprises entrepreneurs, data scientists, software engineers, and medical professionals united in our mission to revolutionize cancer diagnostics through artificial intelligence, ultimately enhancing patient care. As the volume of tests continues to rise annually, pathologists face significant challenges in delivering precise and timely analyses. To address this, Ibex harnesses the power of AI to create clinical-grade solutions that aim to identify cancer with the same level of accuracy as a human pathologist. The Galen Platform employs advanced algorithms to scrutinize images, detect and classify cancer in biopsy samples, and highlight other clinically significant findings, thereby assisting pathologists in minimizing diagnostic errors while streamlining their workflow. Notably, Ibex’s Galen™ Prostate and Galen™ Breast solutions represent the pioneering AI-based cancer detection tools integrated into routine clinical practice in pathology labs, showcasing proven efficacy in uncovering previously missed cancer cases. As we continue to innovate, our commitment to improving cancer detection and patient outcomes remains unwavering.

The integration of artificial intelligence is set to revolutionize the field of healthcare diagnosis. By leveraging AI and predictive analytics, we can achieve early detection of diseases and enhance diagnostic accuracy. Our cloud-based AI platform aims to make healthcare more affordable and accessible for everyone. Endimension Technology, a healthcare AI startup fostered at IIT Bombay, specializes in developing advanced algorithms that identify abnormalities and diseases from medical imaging. Our team comprises experts in machine learning, software engineering, and medical professionals from esteemed institutions. We are dedicated to creating AI-driven healthcare solutions that will significantly minimize the incidence of patient misdiagnosis. Furthermore, our technology is designed to alleviate the workload of radiologists while simultaneously improving the speed at which patients receive their results, ultimately leading to better healthcare outcomes. By harnessing the power of AI, we envision a future where diagnostic processes are more efficient and reliable.

Concentriq, our advanced AI-driven software platform, operates at the crucial crossroads of digital and computational pathology, merging essential functionalities for routine pathology tasks with robust AI tools that enhance innovations and elevate patient care quality. Pathology laboratories around the globe are acutely aware of the contemporary hurdles, which include an escalating cancer incidence, a shortage of trained pathologists, diminishing reimbursement rates, and the urgent need for modernization. In this context, with one billion pathology slides projected to transition to digital formats annually, generating enormous volumes of new data and insights, the urgency to act is undeniable. Digital pathology equips today’s progressive pathology organizations with the resources necessary to tackle these challenges effectively, thereby revolutionizing our operational methods and significantly impacting the fields of medicine and patient treatment. As this transformation unfolds, the potential for improved diagnostics and enhanced patient outcomes continues to grow exponentially.

The product evaluates a patient's risk level to create a tailored digital screening plan, ensuring more reliable follow-up recommendations and enhancing diagnostic accuracy. This strategy is particularly effective in identifying cancers in women who are at heightened risk. WRRisk integrates a fully digital breast cancer risk assessment that utilizes patient-completed digital forms alongside a density evaluation to generate a comprehensive risk scorecard. By automating numerous manual processes, such as form collection and letter creation, WRRisk streamlines the management of breast risk programs, eliminating the need for paper documentation. This innovative product empowers both patients and healthcare providers with essential information, enhancing the overall care experience. Additionally, WRRisk provides calculations for ten-year and lifetime risk, as well as assessments based on secondary density metrics.

The Kanteron Platform assimilated a wide array of medical images, digital pathology slides, genomic sequences, and patient information from various modalities, scanners, sequencers, and databases, delivering a comprehensive data toolkit to all teams within hospital networks. It emphasizes pharmacogenomics to avert adverse medication events and facilitates the application of precision medicine at the point of care by integrating data sources on drug-gene interactions that were formerly only accessible in less user-friendly formats, such as tables found in PDF documents. By incorporating major pharmacogenomic databases like PharmGKB, CGI, DGIdb, and OpenTargets, it enables users to customize their queries according to specific gene families, types of interactions, and drug classifications. Additionally, its adaptable AI allows users to select the dataset that best aligns with their specific use case, applying it effectively to pertinent medical images. This robust functionality not only enhances the accuracy of medical insights but also fosters a more personalized approach to patient care.

Cloud Pathology (CP) is transforming the landscape of diagnostics in the modern era. By leveraging cutting-edge cloud computing technology, it enhances the efficiency of pathology laboratories by an impressive 80%. This innovative system connects seamlessly with all compatible equipment, allowing for streamlined operations. Enjoy a more relaxed lifestyle as Cloud Pathology handles the more demanding tasks, enabling you to oversee processes without stress. It's designed to be the ultimate solution for managing your laboratory needs. Accessible from any device worldwide, pathologists can now review and finalize their reports without the need to rush back to the lab. This advancement not only conserves critical time but also boosts overall efficiency by 35%. Once reports are verified by the responsible physician, they can be automatically dispatched without any manual effort required. Our philosophy prioritizes automation, minimizing human involvement wherever possible. The system is programmed to alert you only when your attention is necessary, ensuring a smooth and efficient workflow. With Cloud Pathology, the future of lab management is not just promising—it's here.

GestPath serves as a comprehensive management system for anatomic pathology procedures, effectively digitizing the entire workflow and addressing the needs of all users involved. By incorporating features such as full traceability, management tools, quality control mechanisms, and security measures at every stage, GestPath enhances the diagnostic process while ensuring standardized task execution. This system not only offers complete oversight for an anatomic pathology department but also contributes to a reduction in operational costs associated with its functions. Additionally, GestPath’s ability to streamline processes aids in improving overall efficiency and accuracy in the pathology field.

ACGIL offers a versatile information module designed specifically for pathology labs, enabling the efficient dissemination and recording of data related to all tests conducted within the facility. This system empowers users by allowing them to receive online requests from physicians while also permitting laboratory staff to generate new requests. The pathology lab software is integrated to centralize the entire database and various modules of hospitals, clinics, and medical laboratories into one cohesive interface. Users can effortlessly access and manage information regarding pre-booking, online request receipts, test billing, report delivery, and much more through this streamlined system. Additionally, our clinical lab software plays a crucial role in accurately maintaining records of every test conducted across different disciplines, including Cytology, Hematology, Biochemistry, Serology, and Neurology, ensuring comprehensive data management. Overall, this software solution enhances operational efficiency and improves communication between healthcare providers and laboratories.

The red dot® algorithm we utilize swiftly identifies and highlights irregularities in images with remarkable precision. This advanced AI system has been crafted using a dataset of over 30,000 images, all meticulously evaluated by certified Consultant Radiologists from the UK. With continuous refinement by these highly skilled professionals, our red dot® algorithm maintains an impressive accuracy rate exceeding 90%. The ability to detect abnormalities in mere seconds ensures that patients receive diagnoses even before they leave the hospital. Furthermore, our AI technology enhances current reporting processes and seamlessly integrates with existing Radiology Information Systems (RIS) or Picture Archiving and Communication Systems (PACS), regardless of the vendor. Behold.ai has proven to be a highly cost-efficient solution, effectively alleviating reporting backlogs and capacity challenges while being up to 50% less expensive than outsourced reporting options. Recognized globally, behold.ai has earned a spot among the Top 100 Digital Health companies and is one of only five selected for AI diagnosis worldwide, showcasing its commitment to innovation in healthcare. This recognition underscores the transformative impact our technology is having on medical diagnostics and patient care.

At PathAI, we are dedicated to enhancing patient outcomes through trustworthy AI-driven technology and meaningful partnerships, with the goal of delivering the most precise diagnoses and effective treatments to patients. Our innovative translational platform, supported by our skilled team of scientists, biostatisticians, and machine learning experts, uncovers and examines new cellular and tissue patterns to identify pathology-related features that yield groundbreaking insights throughout all stages of drug development and various therapeutic domains. By employing dependable and consistent technology, our platforms aim to reduce observer variability and enhance patient selection and stratification, ensuring that the most suitable patients are included in each trial, thereby boosting the likelihood of successful outcomes. Additionally, our technology establishes the most accurate cut points, allowing us to enhance precision and maximize the number of patients who test positive for biomarkers, ultimately contributing to more effective treatments. This commitment to excellence positions us at the forefront of transforming healthcare through advanced analytics and collaboration.

The expenses, intricacies, and lengthy timelines tied to traditional methods of evidence generation hinder the agile nature of research and the broader incorporation of genuine patient insights within treatment development and commercial processes. Our HyperStream serves as the largest real-time stream of patient experience data globally, documenting the genuine digital narratives of diseases as expressed by real patients on various online platforms. Pharos acts as a web-based tool for evidence generation and a research framework that leverages its combined data streaming and AI functionalities to effectively gather online patient experience data, allowing teams to swiftly uncover vital evidence when necessary. Thus far, the Pharos Suite has proven effective in generating valuable evidence and patient insights across a variety of therapeutic areas and medical conditions, demonstrating its versatility and impact on research practices. This innovative approach not only enhances the speed of evidence gathering but also enriches the understanding of patient experiences in real-time.

Volpara Health software is utilized by various facilities, including leading cancer screening centers in the United States, to facilitate the early detection of breast cancer. Mammography technologists depend on this software to enhance the quality of mammograms. Recognized as the most scientifically validated screening tool in the breast health sector, Volpara provides essential evidence at critical moments. It offers access to comprehensive patient data, enabling more accurate assessments of breast cancer risk. Each analyzed image contributes to refining our algorithms for early detection of the disease. Your support is crucial in promoting additional screening or genetic tests for patients. The platform allows for the creation of tailored worklists and reports according to individual preferences. Users can simultaneously view statistics and lists from a single interface, making the process more efficient. Communication can be standardized across patients, referrers, and insurers, ensuring clarity and consistency. Furthermore, it enhances the delivery of result letters by incorporating thumbnail images of mammograms, making the information more engaging and informative. This multifaceted approach ultimately promotes better patient care and outcomes in breast health.

Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.

By fostering robust partnerships with top Contract Research Organizations (CROs), we provide an innovative approach to the secure onboarding and evaluation of research studies. Our exceptional user experience in study management and image analysis, combined with integrated artificial intelligence, greatly enhances the productivity of our pathologists. The cutting-edge cloud-based system facilitates immediate collaboration between pharmaceutical companies and CRO partners globally, regardless of location. Users maintain comprehensive control over the configuration of their studies, accommodating various types of associated data, study sizes, and formats from Whole Slide Imaging (WSI) vendors, including capabilities for SEND data representation and LIMS integration, all presented through an easy-to-navigate interface. We combine efficient workflow design, outstanding viewing performance, and user-friendliness to create a distinctly superior digital pathology experience. Patholytix Preclinical stands as a fully scalable solution that adapts to the evolving needs of your organization, ensuring seamless access to studies whether in the office or working remotely. This adaptability not only enhances operational efficiency but also empowers teams to collaborate more effectively in a rapidly changing research landscape.

VSI HoloMedicine® by apoQlar is an innovative software platform that utilizes Microsoft HoloLens 2 technology to revolutionize medical imaging, clinical processes, and educational methods within a groundbreaking 3D mixed reality framework. Move beyond traditional textbooks and explore VSI’s extensive digital repository of authentic medical images, case studies, and volumetric 3D mixed reality lectures. Enhance your students' understanding of structural relationships and anatomy by providing them with advanced segmentation tools. This platform allows users to engage with real human anatomy cases and intricate pathology visuals in an unprecedented way. By integrating these tools, you can make anatomical comprehension much more accessible for your learners. Our approach to transforming medicine is comprehensive, as we have redefined clinical workflows to utilize the potential of medical mixed reality effectively. Our dedicated medical advisory board, consisting of nearly 30 specialized physicians from around the world, guides our research and development efforts to guarantee clinical accuracy and relevance. With this collaboration, we aim to ensure that the advancements we make are truly beneficial to the medical community.

Diagnosis refers to the process of determining what disease or condition is causing a person's symptoms and test results. DDxHub – Differential diagnosis Hub is a system that distinguishes a specific disease or condition from others with similar symptoms and lab results. DDxHub is a concentrator which holds a lot disease descriptions. DDxHub can be useful when you are trying to find the right diagnosis by comparing multiple diagnoses. You can upload your own disease definition to DDxHub repository, and then share it with other DDxHub users worldwide. You will receive disorder descriptions from other DDxHub users in return. Join thousands of healthcare professionals and patients who already love DDxHub’s differential diagnosis, sync, disorders description sharing solution. DDxHub can be used by medical students in clinical therapeutics as an educational resource.

OneLABz is a comprehensive management system designed specifically for pathology labs. This web-based platform streamlines all laboratory operations, ensuring full automation from the moment a sample is collected to the delivery of test results online, via email, or SMS. The Pathology Lab Management System prioritizes efficiency with rapid reporting and electronic medical record capabilities. It features a robust and secure interface that facilitates the management of patient details, doctor and employee registrations, automated chemical stock oversight, and user access controls. Additionally, it tracks lab expenses, collected samples, and generates various reports, ultimately enhancing transparency and profitability. By utilizing this software, pathology labs can significantly reduce costs and improve their overall operational efficiency, ensuring a seamless integration of all lab activities. This innovative solution not only benefits lab staff but also enhances the patient experience by providing timely and accurate results.

We are confident that Waveform AI has the potential to significantly enhance the healthcare landscape, and we are developing a platform designed to equip clinicians with essential information and support throughout the entire care continuum. Transforming healthcare truly requires collective effort, and to play our part in advancing the industry, we are publishing peer-reviewed research on AI to illustrate its benefits at every stage of the patient care experience. Our platform aims to assist providers in identifying individuals at high risk for sleep apnea by leveraging data from electronic medical records, waveforms, wearables, and various other sources, facilitating timely referrals for diagnosis. By utilizing this data, we can aid healthcare providers in pinpointing the most critical patients among the vast undiagnosed population, categorizing them based on their risk for adverse outcomes and potential healthcare costs. Additionally, we strive to streamline the diagnostic process for clinicians, enabling them to treat more patients efficiently and effectively by improving the overall quality and speed of sleep apnea diagnoses. In doing so, we hope to foster a healthier future for all patients.

Pathology Reporting Software stands out as one of the premier Diagnostic Center Management Software options in India, serving also as a Referral Laboratory Software. It is designed to function in both a network-based and standalone model, making it versatile for various operational needs. Additionally, it can serve as diagnostic center billing software, proving its utility across different applications. This fully tested and reliable pathology laboratory software simplifies tasks with features like report generation, lab accounting, and stock entry, thereby enhancing workflow efficiency. The software provides pathology labs with a highly adaptable data module specifically intended for the distribution and recording of information related to all tests conducted in the lab. It is specifically designed to centralize the entire database and modules of clinics, medical laboratories, diagnostic centers, and pathological laboratories into a single unified interface. Information related to test billing, report delivery, and various other functions can be easily accessed and maintained through this comprehensive system, ensuring seamless operation in busy lab environments. Ultimately, this software not only streamlines processes but also significantly improves the accuracy and reliability of lab operations.

Saral-Path, a pathology laboratory software, allows for fast and easy reporting of all types of pathology tests. Saral Path facilitates Accounting for a pathology lab, such as patient records, referred doctors accounts, centre-wise accounting, and analytical analysis on how improve and expand the lab work. Saral-Path, the company's selling software, gets 75% of its business. It is not only a report printing software, but also a lab manager that helps track user work, visit patient history and an e-reporting system which saves paper and gives you a fast report delivery, manages kit stock, and gives you an alarm for expiry and short stock.

Pathology Reporting Software efficiently handles patient records within a Pathology Lab environment. This tool enables the entry of patient test results and generates reports for patients. Additionally, it supports basic accounting functions, such as automating patient billing and calculating doctor incentives. It is designed to cater to the diverse needs of both small and large pathology practices. The software allows for unlimited data storage, utilizing the full capacity of available hard disk space. Users can delete patient records based on date ranges or specific patient codes, and if desired, past records can be permanently removed. Furthermore, it provides the capability to access Patient Test History for reference, making it easier to review previous tests and results for regular clients. Comprehensive reporting features are available for doctors and management information systems, fulfilling all reporting requirements essential for operational management. Moreover, the software allows for simultaneous usage across multiple systems, enhancing efficiency in a collaborative work environment.

We combine clinical and experimental data through machine learning techniques to explore human disease biology and promote the development of precision medicine. Our innovative Contingent AI™ technology comprehends the intricate relationships present in the data, yielding advanced insights. To combat data bias, we refine our machine learning models based on decisions made during the pre-processing and feature engineering phases. We utilize zebrafish, cellular, and various phenotypic animal models to test and confirm in silico predictions through in vivo experiments, along with genetic modifications conducted both in vitro and in vivo to enhance translation. By employing active learning and computer vision on validated models that focus on cardiac, central nervous system, and rare disorders, we swiftly integrate new data into our machine learning frameworks, allowing for continuous improvement and adaptation in our methodologies. This iterative process not only enhances the accuracy of our predictions but also enables us to stay at the forefront of research in precision medicine.

Labsmart is a comprehensive online management solution designed for pathology laboratories and diagnostic centers. It transforms the conventional offline desktop pathology lab software into a web-based system, enabling real-time information access for both patients and physicians. Employed by over 1,100 labs across India and internationally, Labsmart, as a Software as a Service (SaaS) platform, is experiencing swift growth. Daily, more than 1,500 users rely on this application to manage their business activities efficiently. Labsmart aims to provide a high-quality and cost-effective option specifically tailored for small to medium-sized laboratories, ensuring they can leverage modern technology for improved service delivery. As the demand for efficient lab management continues to rise, Labsmart positions itself as a vital resource in this evolving market.

No doctor should have to navigate through mountains of chaotic patient information. Our streamlined and user-friendly platform effectively structures even the most intricate cases, ensuring that fast evaluations and proactive treatment are accessible to all. It provides a thorough, concise, and context-aware clinical summary. Navina seamlessly integrates with your electronic health records, as well as claims data and a variety of patient information. This actionable synthesis at the point of care enhances the quality of treatment while also boosting reimbursement rates. It is all too common for essential data to be lost within the depths of the EHR system. By leveraging AI technology, Navina brings that vital information to the forefront and displays it in a clear and intuitive manner. In addition, we utilize data analytics to identify and propose potential diagnoses and offer other clinical insights derived from often overlooked discharge documents, laboratory results, and various other records. Ultimately, our goal is to empower healthcare professionals with the tools they need to provide the best possible care.

Enhance the effectiveness of antimicrobial use in hospitals by equipping prescribers and Antimicrobial Stewardship Program (ASP) members with our innovative AI-driven software, ZEVAC. The challenge of antibiotic resistance represents a critical public health concern today. ZEVAC is an advanced AMS software harnessing the power of AI to assist hospitals in eliminating unnecessary or improper antibiotic prescriptions. It employs a scientific yet unconventional methodology in combating the rise of antimicrobial resistance (AMR). By utilizing ZEVAC, clinicians can access precise and tailored antibiotic susceptibility predictions, which are informed by patient demographics, clinical details, local hospital prevalence, susceptibility trends, and historical culture data. In addition, ZEVAC empowers ASP members by providing proactive strategies to prevent inappropriate antimicrobial use through its real-time analysis of comprehensive hospital clinical data, ultimately fostering a more responsible approach to antibiotic stewardship. This multifaceted approach not only aids in individual patient care but also contributes to the broader goal of preserving antibiotic efficacy for future generations.

Pulse is a cloud-based solution designed for echocardiography labs aiming to enhance efficiency and patient outcomes. This platform facilitates reporting, storage, and analysis of echocardiograms, ensuring that you can access patient information whenever and wherever it's needed. Physicians benefit from the ability to review studies and finalize reports from virtually any location, making it an essential tool for contemporary echocardiography practices. With a user-friendly and robust reporting interface conveniently located alongside images and measurements, Pulse empowers users to navigate their tasks seamlessly. Its AI-driven features allow for fully automated measurements of GLS, LVEF, LVEDV, and LVESV, eliminating the need for manual input. Furthermore, the platform minimizes security risks while maximizing the advantages associated with cloud-native technology. Reports can be sent directly to your electronic health record (EHR) via HL7, effectively streamlining clinical workflows. You can easily store new studies right from the cart or retrieve existing studies from an external PACS. Moreover, integrated support for DICOM-TLS simplifies the management of secure data access, sparing users from the complexities of VPN setups. Overall, Pulse is revolutionizing the way echocardiography labs operate by combining technology with clinical expertise.

Wayfinder serves as a comprehensive SaaS platform designed for big data in the healthcare and life sciences sectors, seamlessly integrating data, analytics, and AI processes to expedite the extraction of insights essential for these industries. This innovative solution enables quicker access to detailed insights derived from healthcare data. Utilizing the robust Databricks Lakehouse framework, Wayfinder provides connectivity to over 45 terabytes of de-identified and enhanced claims data, designed to cater to the specific data handling and processing demands of the healthcare and life sciences sectors at a large scale. By leveraging Wayfinder, users can scrutinize high-quality claims data to pinpoint rare patient populations, target healthcare providers effectively, construct detailed patient journeys, and uncover significant market trends, all while providing the granular detail necessary to inform strategies that foster differentiation and growth. With Wayfinder, the focus shifts from data preparation and management to in-depth analysis, empowering stakeholders to make informed decisions and drive innovation in their practices. This platform not only enhances efficiency but also positions users to leverage data more strategically for future advancements.

Watson Health leverages its foundational strengths, extensive expertise in the healthcare sector, and cutting-edge technological offerings—such as AI, blockchain, and data analytics—to empower clients in their digital transformation journeys. By integrating innovative technology with seasoned consulting services, we assist organizations in becoming more efficient and resilient, ultimately enhancing their ability to fulfill their commitments to the communities they serve. Explore the Watson Health solutions designed to optimize clinical, financial, and operational effectiveness while also applying analytics to improve initiatives aimed at vulnerable populations. Additionally, our offerings enhance clinical trials and facilitate the generation of real-world evidence, which is crucial for advancing healthcare practices. We also provide solutions that enable payers to effectively manage performance, member engagement, and business networks. Furthermore, Watson Health assists organizations with benefits analytics and ensuring business continuity, making us a comprehensive partner in the healthcare landscape. This multifaceted approach highlights our commitment to driving positive outcomes across various facets of health systems and enhancing overall service delivery.

We are entering a transformative phase in predictive analytics, particularly focusing on healthcare data management, through innovative machine learning tools and tailored applications specifically for the healthcare sector. Lumiata’s advanced cost and risk forecasting capabilities consistently surpass traditional techniques, revolutionizing risk management and care delivery within the healthcare landscape. Whether it’s underwriting, care management, or pharmaceuticals, Lumiata provides comprehensive solutions. Our sophisticated applications and data science tools foster an adaptable and cooperative alliance with payers, providers, and digital health entities. Discover the promise of AI innovation with us, as we empower your data science teams with essential ML productivity tools. The journey begins with our unique data preparation and cleansing methodology, where raw data is seamlessly ingested, purified, and structured into an accessible format that is primed for machine learning applications, ensuring that your organization can leverage the full potential of its data.

Created by American Soft Solutions, Prolis serves as a sophisticated laboratory information management system tailored for healthcare facilities and reference laboratories, regardless of their scale. Specifically designed for multi-specialty labs, it is utilized across various fields such as microbiology, chemistry, pathology, coagulation, molecular diagnostics, and toxicology, enabling users to streamline and automate their laboratory operations effectively. Key features of Prolis encompass physician panels, a barcode system for laboratories, patient scheduling, comprehensive audit trails, logistics oversight, remote accessioning capabilities, as well as integrated billing and reporting functions. Additionally, Prolis includes a powerful search tool for physicians, enhancing the overall efficiency of laboratory management, and offers a wealth of other functionalities to support diverse laboratory needs.

Aarogya, a comprehensive Hospital Management Information System, includes functionalities like OPD Management, IPD Management, OT Management, TPA Management, Pathology Lab Management, Inventory Management, Finance and Accounting Management, and Blood Bank Management, among others. The system is designed to operate during standard business hours and provides round-the-clock live support. This dependable software solution caters to the needs of mid-sized to large hospitals, diagnostic labs, and polyclinics, ensuring streamlined operations and improved patient care. It also emphasizes efficiency and adaptability, making it a valuable resource in the healthcare sector.

The system is versatile and applicable across various fields such as Clinical Biochemistry, Hematology, Microbiology (including Bacteriology), Cytology, Histology (both Anatomical and Cellular Pathology), Virology, Serology, Immunology, Toxicology, Tuberculosis, Environmental and Public Health, External Quality Assessment (EQA), Veterinary practices, Clinical Trials, and numerous other medical laboratory scenarios. It is designed to scale efficiently, accommodating everything from single workstations in remote locations to extensive networks of hundreds of workstations in major hospitals, and it serves both small private laboratories and multiple public facilities that cater to entire nations, proving that no laboratory is too large or too small for this solution. The deployment process is straightforward, particularly for smaller labs that may lack internal IT support, as a pre-configured MS-SQL based system is available, allowing them to become operational in just a few days. For larger laboratories, we provide systems that utilize MS-SQL, MySQL, or Oracle, enabling these facilities to customize and continually refine their setups as needed, with comprehensive implementation and training services offered to assist them; such large labs can be fully functional in as little as a month, ensuring they can efficiently meet their operational demands. This adaptability and support make our system a reliable choice for laboratories of all sizes.

Enhance patient care by using the only objective, quantitative arterial analysis software validated through histology and based on CTA technology. This innovative tool employs ground-truth histological data to reveal the origins of myocardial ischemia, helping to assess risks for heart attacks and strokes. These critical events are often driven by unstable, non-obstructive plaques within the arteries that remain undetected and unaddressed. Traditional non-invasive diagnostic methods fall short, as they cannot penetrate deep into the arterial walls where heart disease begins to manifest. Elucid is leveraging advanced scientific imaging alongside artificial intelligence to facilitate rapid, reliable, and non-invasive diagnoses, ultimately leading to tailored treatment strategies for cardiovascular conditions and improved patient outcomes. With this histology-validated software, you can evaluate plaque composition and determine the risks of heart attacks and strokes with unmatched precision. This comprehensive, objective visualization of arterial health empowers healthcare providers to devise customized treatment approaches well before a patient arrives for hospital care, significantly enhancing the quality of healthcare delivery.

VIPER streamlines the process of screening by automating remote patient identification right at the diagnosis stage and ensuring qualified enrollment. By leveraging artificial intelligence, VIPER efficiently matches patients to precision trials during a critical enrollment period by utilizing lab-agnostic genomic data, electronic medical records (EMR), and pathology information tailored to both the patient and the research requirements. The system employs a specialized matching engine that searches for the most suitable clinical trials corresponding to a patient's specific diagnosis at the moment they receive it. Additionally, through seamless workflow integration, VIPER provides real-time alerts regarding a patient’s eligibility for available trials, ensuring the entire care team is informed during this narrow enrollment timeframe. Furthermore, VIPER features interactive dashboards that offer extensive data mining capabilities, allowing for the aggregation of site and study-level patient data to effectively meet study key performance indicators (KPIs). This comprehensive approach not only enhances trial recruitment efficiency but also supports researchers in achieving their goals more effectively.

HCLAB is a versatile and practical laboratory information system (LIS) that can be tailored to suit the specific requirements of your laboratory. It is designed to enhance efficiency in everyday operations and is applicable across various medical and diagnostic fields, including hematology, immunology, biochemistry, microbiology, urinalysis, coagulation, and both molecular and anatomical pathology. With its scalable nature, HCLAB is perfect for laboratories of all sizes, ranging from small specialized sites to intricate multi-site healthcare organizations and academic hospitals. The system provides comprehensive information management, covering every aspect from initial test requests to the final reporting and delivery of results. HCLAB offers a smart client workstation that allows clinical personnel to access the system via the web, facilitating order requests and enabling seamless order entry right from the laboratory. Additionally, it effectively manages and monitors samples sent to external laboratories for tests that cannot be conducted in-house, ensuring a smooth workflow throughout the entire testing process. This means that HCLAB not only improves efficiency but also enhances collaboration between different laboratory entities.

Qure.ai's qLC-Suite is a cutting-edge AI-driven tool aimed at improving the early identification and management of lung nodules, which is crucial for prompt lung cancer intervention. This solution delivers accurate measurements, thorough characterization, and 3D imaging of lung nodules, ensuring that opportunities for early treatment are not overlooked. It is capable of supporting both incidental and targeted screenings by efficiently identifying nodules and calculating their volume with just one click. Moreover, the system monitors volumetric changes over time, providing valuable insights into nodule development. The qLC-Suite is designed to integrate smoothly into current workflows, offering quick analysis and reporting that assist healthcare professionals in their decision-making processes. In addition to its analytical capabilities, it serves as a comprehensive platform for managing lung nodules, facilitating care coordination through intelligent prompts, providing hardware-agnostic image viewing for AI-enhanced chest X-rays and CT scans, enabling seamless sharing of scans across departments, and allowing for tailored notifications for cases of concern. Overall, qLC-Suite represents a significant advancement in lung cancer care, promoting timely interventions that can ultimately save lives.

The Sentinel system incorporates the sample container and cassette to capture an image of both the tissue and the label on the container. It continuously monitors the usage of containers and cassettes to prevent any potential mix-ups of specimens. During the transfer of tissue into the cassette, the Sentinel efficiently identifies, measures, and photographs each tissue piece. A gross report is automatically generated using the laboratory's specific template, which the technician reviews and subsequently adds to the patient’s records. In less than a second, the Sentinel precisely locates, measures, and images the tissue as it is placed into the cassette. Its measurements are notably more accurate and reliable compared to those taken manually by technicians. Additionally, the system produces visually appealing, full-color reports that include a gross description, details of the patient and clinician, as well as images of the container, its label, and the cassette itself, ensuring comprehensive documentation of the specimens. This advanced technology enhances the overall efficiency and accuracy of the specimen handling process.

AarogyaAI is a software-as-a-service platform that utilizes artificial intelligence to identify drug-resistant tuberculosis (DR-TB) within hours. Our goal is to provide rapid and precise diagnoses of DR-TB, ensuring that patients receive the most effective drug combinations for their treatment without delay. Tuberculosis is responsible for more fatalities annually than AIDS, largely because the 19 available anti-TB medications do not work for all patients, leading to uncertainty among doctors regarding the appropriate treatment options. Consequently, even though tuberculosis is treatable, a delayed diagnosis of drug-resistant forms can result in patients remaining on ineffective medications for as long as seven years. By diagnosing drug-resistant tuberculosis swiftly, we enable prompt and appropriate treatment prescriptions. Patients upload a DNA sequence to our platform, and our advanced machine learning algorithm processes this data to generate a detailed report on drug susceptibility status, allowing healthcare providers to make informed decisions about treatment. This innovative approach not only enhances patient outcomes but also aims to reduce the overall burden of tuberculosis on healthcare systems.

WRDensity supports radiologists in evaluating breast density, promoting consistency in density assessments across their practices. Its primary aim is to facilitate early detection while ensuring patients feel reassured through enhanced consistency, confidence, and overall quality of care. Developed using advanced deep learning techniques, WRDensity analyzed over 600,000 images sourced from the esteemed Mallinckrodt Institute of Radiology, known for its pioneering work in the field. This robust deep learning model excels in providing precise classifications of breast density. Additionally, the batching and sorting features can boost user productivity by as much as 20%. By integrating WRDensity into the radiologist's existing workstation, critical information regarding tissue density is readily accessible in a relevant context, further enhancing the diagnostic process. Ultimately, this innovation not only streamlines the workflow but also contributes to improved patient outcomes.

Enhance your examination capabilities from any location and boost patient outcomes with intuitive, real-time imaging that is both economical and highly portable. Introducing the groundbreaking 3rd generation portable ultrasound, which is now 30% smaller and lighter than its predecessors. The Clarius HD3 offers unparalleled portable ultrasound technology tailored for your specific specialty, featuring a user-friendly app driven by artificial intelligence and seamlessly integrated with cloud connectivity. With the Clarius HD3, you can expect crisp and clear imaging that makes it simple to pinpoint anatomy, accurately diagnose conditions, and guide procedures in real-time right at the patient's side. This innovative device is equipped with artificial intelligence, 192 piezoelectric elements, and an impressive eight beamformers, which together provide the superior performance typically associated with cart-based systems, all while maintaining the lightweight feel of a conventional probe. As we move towards a future where smart devices operate without ports, the Clarius HD3 incorporates cutting-edge antenna technology designed for the most dependable direct WiFi connection to your mobile iOS or Android devices, eliminating the need for ports or cables altogether, thus ensuring maximum convenience. This advancement represents a significant leap forward in diagnostic imaging technology.

Join AI is transforming the healthcare landscape with AI-powered tools designed to assist in radiology and endoscopy diagnostics. The platform offers AI-driven solutions for chest imaging, breast imaging, stroke detection, and gastrointestinal endoscopy, enabling clinicians to detect conditions like lung diseases, breast tumors, and gastrointestinal infections more efficiently. Join AI’s algorithms provide deeper insights, aiding in early diagnosis and faster decision-making, which are crucial for improving patient care and treatment outcomes. With seamless integration into existing workflows, the platform empowers healthcare professionals to make more confident decisions.

Founded in 2016, Infervision stands at the forefront of AI-driven medical technology, dedicated to enhancing multidisciplinary healthcare services and operations through innovative artificial intelligence solutions. Their advanced AI offerings are designed to assist healthcare professionals across a spectrum of tasks, including disease screening, diagnosis, intervention, treatment, patient management, and medical research. Among their array of solutions, InferRead CT Lung specializes in detecting lung nodules from chest CT scans, while InferRead DR Chest focuses on identifying chest abnormalities via X-ray imaging. Moreover, InferRead CT Coronary is tailored for recognizing coronary artery stenosis during coronary CT angiography, and InferRead CT Stroke is adept at triaging hemorrhages from brain CT scans. The company also provides InferRead CT Bone for spotting chest fractures in CT images and InferRead CT Pneumonia for diagnosing and managing pneumonia cases. Beyond these, their offerings extend to InferOperate, which facilitates 3D reconstruction for thoracic, liver, and urological surgical procedures, and InferCare, a tool designed for effective patient management and image follow-up. Additionally, InferScholar acts as an AI-enhanced resource for medical research, further solidifying Infervision's commitment to transforming healthcare through AI technology. This comprehensive suite of solutions positions Infervision as a pivotal player in the evolution of medical practices.

Cardiovascular diseases result in more than 20 million fatalities globally each year, many of which could be avoided through timely detection. Unfortunately, the healthcare sector is often stretched thin, hindered by the limitations of human analysis capabilities. This is where AIATELLA makes a significant impact. Our innovative AI-driven image analysis technology revolutionizes cardiovascular diagnostics. By automating the intricate measurements of blood vessels and leveraging historical data, we substantially reduce the time, expenses, and required expertise, thereby enhancing the potential for vital imaging procedures. AIATELLA's approach not only accelerates the diagnostic process but also boosts the precision and reliability of results, providing critical measurements and disease progression insights in mere seconds rather than hours. As a result of this increased efficiency and accuracy in analyses, healthcare providers can dedicate more time to patient care, ultimately paving the way for effective preventative strategies and personalized treatment options for everyone. This shift could redefine how we approach cardiovascular health on a global scale.

LabAnalyzer is an innovative platform that utilizes artificial intelligence to make the interpretation of medical lab tests easier and more accessible. Users have the ability to upload their lab results in various formats such as PDF, image, or text, and they receive immediate and precise explanations of their medical information. Thanks to its advanced AI technology, LabAnalyzer offers comprehensive analyses of crucial metrics, identifies potential health concerns for users to discuss with their healthcare providers, and provides translations in several languages. Notable features include the ability to upload PDFs, images, and text with OCR capabilities for extracting text, in-depth AI-generated insights into lab metrics like glucose and cholesterol levels, real-time language translation for reports, and a secure platform that is both user-friendly and budget-friendly, starting at just $5. LabAnalyzer's mission is to empower individuals to gain a clearer understanding of their health data and to facilitate informed healthcare decisions. Additionally, the platform continually enhances its features to ensure users are well-equipped to manage and interpret their medical laboratory results effectively.

Us2.ai is revolutionizing the battle against heart disease by utilizing AI-driven ultrasound software that ensures heart health can be accessible to everyone. This innovative platform provides 45 automated echo parameters, such as strain analysis, and enables real-time interpretation of 2D and Doppler images. It seamlessly integrates with any ultrasound machine, producing zero-click, comprehensive reports that maintain high accuracy and can be easily compared with expert evaluations. The AI echo copilot from Us2.ai autonomously analyzes all heart chambers through both 2D and Doppler perspectives, incorporating global reference guidelines into detailed, real-time reports. Recently, the software obtained FDA clearance for Us2.v2, which also boasts 45 automated echo parameters, including strain analysis, representing a remarkable advancement in healthcare technology. Ultimately, Us2.ai aims to democratize echocardiography, ensuring that ultrasound technology is available to individuals regardless of their location or circumstances, thereby promoting better heart health for all. This commitment to accessibility and innovation positions Us2.ai at the forefront of the medical technology landscape.